This presentation will begin with a brief review of ocular surface disease, including definition, risk factors, and how to identify/diagnose. Followed by background on blepharitis (demodex), chalazion, and hordeolum. Particular emphasis will be placed on both 1) modern in-office therapeutic options (i.e. MBE, Thermal Expression, IPL, Amniotic Membrane) as well as 2) updated pharmaceutical options (ie immunomodulators, recently FDA-approved ophthalmic therapies, and new drugs in the pipeline). We will also discuss managing blepharitis with glaucoma patients. If time allows, we will cover Grand Rounds and patient cases.
Almost 2000 attended our event and we received amazing feedback!
Feedback from anonymous survey:
Speakers are always incredible. Great info that we can implement in office.
Very helpful information that I can implement immediately.
Wonderful presentation, concise, organized, great speaker.
I learned valuable information that I will be able to implement into patient care.
Speaker kept the topic interesting especially from first hand knowledge.
Short and sweet! Great presentation!
This was a well constructed, paced and delivered presentation.
Great lecture and speaker. Very engaging and keeps listening interesting.
Speaker: Vin Dang, O.D.
Moderator: Dr. Jen Stewart
COPE ID: 89009-TD
Category: Trt/Mngmnt Ocular Disease
This event is COPE approved for 1 hour of CE credit.
Thank you to Tarsus Pharmaceuticals, Inc. for providing an educational grant for this event.